WallStSmart
OPK

Opko Health Inc

NASDAQ: OPK · HEALTHCARE · DIAGNOSTICS & RESEARCH

$1.11
-8.26% today

Updated 2026-04-29

Market cap
$838.15M
P/E ratio
P/S ratio
1.38x
EPS (TTM)
$-0.27
Dividend yield
52W range
$1 – $2
Volume
2.5M

Opko Health Inc (OPK) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+35.7%
Last 4 quarters
Revenue YoY growth
-19.1%
Most recent quarter
EPS YoY growth
-458.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-3.8%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
-11.2%
2025-07-31
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-02-19$-0.04+46.6%$1.22$1.20-1.6%
2025-10-29$0.03+150.0%$1.44$1.46+1.4%
2025-07-31$-0.19-67.7%$1.34$1.19-11.2%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.07$-0.04+46.6%$148.50M-19.1%
2025-09-30$-0.06$0.03+150.0%$151.67M-12.6%
2025-06-30$-0.11$-0.19-67.7%$156.81M-13.9%
2025-03-31$-0.11$-0.09+13.7%$149.95M-13.7%
2024-12-31$-0.10$0.01+110.0%$183.64M+1.0%
2024-09-30$-0.09$-0.03+66.7%$173.63M-2.8%
2024-06-30$-0.09$-0.01+88.9%$182.19M-31.4%
2024-03-31$-0.09$-0.12-33.3%$173.69M
2023-12-31$-0.09$-0.09+0.0%$181.90M
2023-09-30$-0.10$-0.11-10.0%$178.59M
2023-06-30$-0.07$-0.03+57.1%$265.42M

Frequently asked questions

Has Opko Health Inc beaten earnings estimates?
Opko Health Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +35.7% over the last 4 quarters.
How does OPK stock react to earnings?
OPK stock has moved an average of -3.8% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is Opko Health Inc's revenue growth rate?
Opko Health Inc reported year-over-year revenue growth of -19.1% in its most recent quarter, with EPS growing -458.0% year-over-year.